arrow
M

Mark Berry

Gilead Sciences
H指数:11
被引数:643

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

HMG Box-containing Protein 1 (HBP1) Protects Against Pancreatic Injury in Acute Pancreatitis but Promotes Neoplastic Progression

HMG Box-containing Protein 1 (HBP1) 在急性胰腺炎中保护胰腺免受损伤,但促进肿瘤进展。

2025-05-200
OA
Management of Vulnerable Patients Hospitalized for COVID-19 With Remdesivir: A Retrospective Comparative Effectiveness Study of Mortality in US Hospitals

因Remdesivir新型冠状病毒肺炎住院的易受伤害患者的管理: 美国医院死亡率的回顾性比较有效性研究

2024-10-192
OAAI
Remdesivir Effectiveness in Reducing the Risk of 30-Day Readmission in Vulnerable Patients Hospitalized for COVID-19: A Retrospective US Cohort Study Using Propensity Scores

Remdesivir降低因新型冠状病毒肺炎住院的脆弱患者30天再入院风险的有效性: 一项使用倾向评分的回顾性美国队列研究

2024-10-150
OAAI
Lower Mortality Risk Associated With Remdesivir plus Dexamethasone Versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19

与单独使用地塞米松相比,雷德西韦联合地塞米松治疗因新型冠状病毒肺炎住院的患者的死亡风险更低

2024-09-205
OAAI
Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants

Remdesivir与需要补充氧气的新型冠状病毒肺炎患者的死亡率降低有关,包括跨SARS-CoV-2变体的有创机械通气

2023-09-2218
OAAI
Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice

Remdesivir降低了因变异波新型冠状病毒肺炎而住院的免疫功能低下患者的死亡率: 常规临床实践的发现

2023-08-0934
OAAI
Consensus for Thoracoscopic Lower Lobectomy: Essential Components and Targets for Simulation
2022-11-012
PRE